Alopecia clinical trials
The registry lists 606 studies for Alopecia across more than 10 countries. 128 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 307
- Status unknown
- 74
- Recruiting
- 71
- Not yet recruiting
- 50
- Active, not recruiting
- 36
- Terminated
- 31
Phase
- Phase 2
- 161
- Phase 1
- 70
- Phase 3
- 63
- Phase 4
- 36
- Early Phase 1
- 17
Where
- United States
- 251
- Egypt
- 47
- China
- 42
- Canada
- 27
- Germany
- 25
- Spain
- 25
Who runs them
Assiut University (16) · Aderans Research Institute (11) · University of Minnesota (10) · Applied Biology, Inc. (10) · Suzhou Kintor Pharmaceutical Inc, (9) · Sohag University (9) · Kasr El Aini Hospital (8) · Allergan (8)
Studies
Recruiting first, then most recently updated. Showing 50 of 606 — search for more.
- Tirzepatide for Treatment of CCCARecruitingNCT07734870Phase 21 country
- Phase 2/3 Efficacy and Safety of PP405 in Adult MalesNot yet recruitingNCT07819435Phase 2/3
- A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia AreataRecruitingNCT06873945Phase 311 countries
- HCW9302 (Interleukin-2 Fusion Protein) for Alopecia AreataRecruitingNCT07049328Phase 11 country
- Hair Regrowth Following Partial Thickness Removal of SSCISNot yet recruitingNCT07809191Not applicable
- Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light TherapyRecruitingNCT07810504Not applicable1 country
- Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic AlopeciaNot yet recruitingNCT07516561Phase 31 country
- A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia AreataRecruitingNCT05723198Phase 312 countries
- Efficacy and Safety of Two Hair Supplements in Men With Androgenic AlopeciaNot yet recruitingNCT07806474Not applicable1 country
- A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic AlopeciaRecruitingNCT06916793Phase 31 country
- Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic AlopeciaRecruitingNCT07317544Phase 1/21 country
- Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist UseNot yet recruitingNCT07783113Not applicable1 country
- Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA)Not yet recruitingNCT07671157Phase 21 country
- SCALp Cooling for pReventing aLopecia With nEw anTibody-drug ConjugatesNot yet recruitingNCT07474558Phase 21 country
- Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia AreataRecruitingNCT07617597Phase 31 country
- Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic AlopeciaNot yet recruitingNCT07637071Not applicable1 country
- Blood Specimen Collection For Laboratory Assay ResearchRecruitingNCT060466511 country
- XVIE to Treat Androgenetic Alopecia (AGA)Not yet recruitingNCT07482423Phase 1/21 country
- A Study on the Efficacy and Safety of Microneedling for Male Androgenetic AlopeciaNot yet recruitingNCT07758400Not applicable1 country
- Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic AlopeciaNot yet recruitingNCT03474718Early Phase 11 country
- Comparing Standard Platelet-Rich Plasma and Light-Enhanced Platelet-Rich Plasma for Treating Hair Loss in Androgenetic Alopecia: A Randomized Controlled TrialNot yet recruitingNCT07739147Early Phase 1
- Serum Ferroptosis Biomarkers (GPX4, MDA) in Alopecia AreataRecruitingNCT077330631 country
- For an Investigator-led Hair Study Comparing Between Healthy and Hair Loss VolunteersNot yet recruitingNCT07716748
- Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of ColorRecruitingNCT05213936Not applicable1 country
- Exosome Therapy for Male Androgenetic AlopeciaRecruitingNCT07693244Phase 21 country
- Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia AreataRecruitingNCT05398809Phase 21 country
- Multi-Omics Insights Into Androgenetic AlopeciaRecruitingNCT076035441 country
- 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring AlopeciaRecruitingNCT05460611Not applicable1 country
- Pilot Study to Evaluate the Efficacy and Safety of Xvie Delivered Into the Scalp by Microneedling in Women With Self-perceived Thinning HairEnrolling by invitationNCT07221773Not applicable1 country
- Study Evaluating Xtressé Gummy Supplement in Women With Self-Perceived Thinning HairEnrolling by invitationNCT07224555Not applicable1 country
- Study of EPI-001 in Patients With Androgenetic AlopeciaRecruitingNCT07618195Phase 1/21 country
- A Study of LAD603 in Adults With Alopecia AreataRecruitingNCT07311564Phase 21 country
- VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic AlopeciaRecruitingNCT07536100Not applicable1 country
- Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid TumorsRecruitingNCT04764357Not applicable1 country
- JAK2 Expression in Androgenetic Alopecia Before and After Topical MinoxidilRecruitingNCT07563036Not applicable1 country
- Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.Not yet recruitingNCT07529977Phase 3
- Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-GrowthNot yet recruitingNCT06648850Phase 2/3
- The Effect of Nanofat Injection on Androgenetic AlopeciaNot yet recruitingNCT07518342Phase 41 country
- Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic AlopeciaRecruitingNCT07502976Not applicable1 country
- Topical Application of Lactobacillus Reuteri for Androgenetic AlopeciaRecruitingNCT07370519Phase 21 country
- Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective StudyRecruitingNCT04207931Phase 41 country
- Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia AreataEnrolling by invitationNCT074997131 country
- Assessment of Dutasteride Topical Solution in Male Androgenetic AlopeciaNot yet recruitingNCT07490327Phase 1/21 country
- Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation StudyNot yet recruitingNCT072943131 country
- Androgenic Alopecia TH07 Clinical TrialRecruitingNCT07435012Phase 31 country
- A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic AlopeciaRecruitingNCT07327359Phase 1/21 country
- Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic AlopeciaRecruitingNCT07080931Phase 31 country
- Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia PatientsRecruitingNCT07429253Phase 1/21 country
- Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands RegionRecruitingNCT07422376Not applicable1 country
- Scalp Hair Metabolomics in Severe ObesityRecruitingNCT073688421 country